Trends in disease burden of chronic lymphocytic leukemia at the global, regional, and national levels from 1990 to 2019, and projections until 2030: a population …

Y Ou, Y Long, L Ji, Y Zhan, T Qiao, X Wang… - Frontiers in …, 2022 - frontiersin.org
Background The prognosis of chronic lymphocytic leukemia (CLL) has been improved
dramatically, but there are scarce studies focusing on the disease burden of CLL in the …

Targeting the NF-E2-related factor 2 pathway for overcoming leukemia

MS Harifi-Mood, M Daroudi, M Darroudi… - International Journal of …, 2023 - Elsevier
Leukemia is cancer of the body's blood-forming tissues, including the bone marrow and the
lymphatic system. There are many types of leukemia that some of them occur in children and …

[HTML][HTML] Cancer Burden in China during 1990–2019: analysis of the global burden of Disease

SZ Zhang, L Zhang, L Xie - BioMed Research International, 2022 - hindawi.com
This study reports the risk factors, trends, and burden of cancer in China from 1990 to 2019
from the Global Burden of Diseases. The incidence, mortality, and DALY of all cancers in …

Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia …

X Wang, X Liu, H Wang - Cancer Gene Therapy, 2022 - nature.com
Leukemia ranks as the one of most common causes of death from tumor. 51.4% of patients
with leukemia are over 65 years old. However, the median overall survival (OS) of elderly …

[HTML][HTML] The epidemic of acute lymphoid leukemia in China: current trends and future prediction

W Zhu, S Liu, Y Shi, Q Tang, J Sun, R Bai, Z Sun… - Frontiers in …, 2023 - frontiersin.org
Background China has experienced one of the fastest increases in the incidence of acute
lymphoid leukemia (ALL). The aim of this study was to assess the long-term trends of the …

Antitumor activity and mechanism of action of the antimicrobial peptide AMP-17 on human leukemia K562 cells

Z Tian, L Yang, M Huang, C Sun, M Chen, W Zhao… - Molecules, 2022 - mdpi.com
Cancer is one of the most common malignant diseases in the world. Hence, there is an
urgent need to search for novel drugs with antitumor activity against cancer cells. AMP-17, a …

Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years

D Niu, Y Zhao, J Wang, E Ye, J Huang, J Liu… - Annals of …, 2023 - Springer
Leukemia and its subtypes impose a major public health challenge in China. Identifying the
secular trend of leukemia burden is critical to facilitate optimal healthcare planning and …

Synthesis and characterization of ZnO–TiO2–chitosan–escin metallic nanocomposites: Evaluation of their antimicrobial and anticancer activities

AY Elderdery, AH Alhamidi, AME Elkhalifa… - Green Processing and …, 2022 - degruyter.com
This work intended to formulate bio-nanocomposites of zinc oxide (ZnO), titanium oxide
(TiO2), chitosan, and escin, characterize their physical properties, and evaluate their …

Plantamajoside Inhibits the Growth of Acute Myeloid Leukemia Cells by Modulating NF-κB and PI3K/AKT Signaling Pathways.

X Zhou, G Wang, Q Wu, M Yang - Current Topics in …, 2022 - search.ebscohost.com
Acute myeloid leukemia is a highly invasive and heterogeneous malignant tumor.
Plantamajoside, a natural compound extracted from Plantago asiatica L., has been shown to …

[HTML][HTML] 中国居民1990—2019 年白血病疾病负担趋势分析

戴萌娜, 袭燕, 尹文强, 王相印, 陈钟鸣, 丰志强… - 中国公共卫生, 2022 - zgggws.com
目的了解中国近30 年白血病疾病负担情况及发展变化趋势, 为中国白血病干预与治疗策略的
制定提供参考借鉴.